Viewing Study NCT02258425



Ignite Creation Date: 2024-05-06 @ 3:19 AM
Last Modification Date: 2024-10-26 @ 11:31 AM
Study NCT ID: NCT02258425
Status: COMPLETED
Last Update Posted: 2017-06-20
First Post: 2014-10-02

Brief Title: Homeless Female Offenders Returning to the Community
Sponsor: University of California Los Angeles
Organization: University of California Los Angeles

Study Overview

Official Title: Homeless Female Offenders Returning to the Community Improving Hopeful Futures
Status: COMPLETED
Status Verified Date: 2017-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: FEM-CARE
Brief Summary: In Phase I of this R34 the team from the University of California Los Angeles San Francisco and Irvine researchers plan to utilize the successful community participatory approaches to refine a gender-sensitive criminogenic needs -focused intervention program Female Ex-Offender Mentoring in Care FEM-CARE with the help of a community advisory board composed of homeless female offenders HFOs and addiction staff and finalize strategies which will be validated by focus group sessions with the HFOs In Phase 2 the research team will randomize 130 HFOs participating in one of two residential drug treatment programs to assess the impact of the FEM-CARE or a Health Promotion control program on reduction of drug and alcohol use and recidivism This study is based upon our teams history of promoting theoretically-based culturally sensitive nurse-led interventions that are enriched with criminal justice theoretical perspectives and have resulted in significant reductions in drug and alcohol use among homeless persons many of whom have had a history of incarceration

Specifically the study aims are

AIM 1 Guided by a Community Advisory Board CAB made up of HFOs and addiction staff further conceptualize our community-based program Female Ex-Offender Mentoring in Care FEM-CARE to address the needs and risks of HFOs enrolled in RDT programs and then refine the program in focus group discussions with 12 HFOs

AIM 2 Conduct a pilot RCT to assess the impact of the FEM-CARE program for 65 HFOs at six-month follow-up compared with 65 HFOs receiving a control Health Promotion HP program in terms of a self-reported andor objective measures of drug and alcohol use and b prevalence of recidivism and number of days to first reincarceration

Hypothesis 2a HFOs in the FEM-CARE program will have less drug and alcohol use at six months than HFOs in the HP control program

Hypothesis 2b FEM-CARE HFOs will have a lower prevalence of recidivism by six months and greater number of days to first reincarceration than HP control HFOs
Detailed Description: In the last decade the numbers of incarcerated females has tripled making women the most rapidly growing group of offenders in the United States When compared to incarcerated males female offenders have a higher rate of being sentenced for drug crimes moreover they are often injection drug users IDUs have sexual partners who are IDUs and are often forced into the sex trade for survival As many as 50 of female offenders report physical andor sexual abuse further traumatic abuse chronic emotional distress and internalized stigma resulting from being a felon and a drug-user have a profound effect on the womens self-esteem leading to feelings of hopelessness and depression delayed recovery and reintegration increased risky behaviors and health concerns Not surprisingly women who have been incarcerated are nearly twice as likely to experience mental illness compared with non-offending women further 44 recidivate within a year due to possession of a controlled substance In particular among homeless female offenders HFOs both parolees and probationers report ongoing challenges for successful re-entry These include unstable housing disorganized lives unemployment and limited access to health and social services While the Los Angeles County Department of Probation has provided guidance for successful programs in its California Blueprint Master Plan for Female Offenders the suggested strategies of enhancing empowerment positive coping and job skills and providing peer-mentored approaches have not yet been implemented or evaluated In Phase I of this R34 our team of University of California Los Angeles San Francisco and Irvine researchers plan to utilize our successful community participatory approaches to refine a gender-sensitive criminogenic needs -focused intervention program Female Ex-Offender Mentoring in Care FEM-CARE with the help of a community advisory board composed of HFOs and addiction staff and finalize strategies which will be validated by focus group sessions with HFOs In Phase 2 we will randomize 130 HFOs participating in one of two residential drug treatment programs to assess the impact of the FEM-CARE or a Health Promotion control program on reduction of drug and alcohol use and recidivism This study is based upon our teams history of promoting theoretically-based culturally sensitive nurse-led interventions that are enriched with criminal justice theoretical perspectives and have resulted in significant reductions in drug and alcohol use among homeless persons many of whom have had a history of incarceration Our most recent successes in engaging male parolees in nurse-supported peer mentorship our teams expertise in enhancing stigma reduction among vulnerable women and our criminal justice experts have informed this study Finally recent formative research with HFOs has revealed a desire for peer role models to support and enhance knowledge of and access to healthcare promote positive coping stable housing and job skills and to reduce stigma and depressed mood all of these factors can result in novel programs designed to prevent drug and alcohol use and reduce recidivism This foundation and strong community support garnered has led to the design of our proposed intervention program

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None